RBBP8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.951000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.290600E-01
Normal-vs-Stage2
9.848400E-01
Normal-vs-Stage3
8.709600E-01
Normal-vs-Stage4
5.456400E-01
Stage1-vs-Stage2
1.140810E-01
Stage1-vs-Stage3
4.781000E-01
Stage1-vs-Stage4
1.116150E-01
Stage2-vs-Stage3
7.566400E-01
Stage2-vs-Stage4
2.985400E-01
Stage3-vs-Stage4
3.825000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.946600E-01
Normal-vs-AfricanAmerican
7.550000E-01
Normal-vs-Asian
7.827800E-01
Caucasian-vs-AfricanAmerican
3.915800E-01
Caucasian-vs-Asian
6.192800E-01
AfricanAmerican-vs-Asian
4.357600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.532000E-01
Normal-vs-Female
9.388000E-01
Male-vs-Female
7.224600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.842800E-01
Normal-vs-Age(41-60Yrs)
9.231000E-01
Normal-vs-Age(61-80Yrs)
8.596400E-01
Normal-vs-Age(81-100Yrs)
7.244800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.458500E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.950230E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.333610E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.298400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.876200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.972200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.352600E-01
Normal-vs-Daily Drinker
7.896000E-01
Normal-vs-Weekly Drinker
6.514000E-01
Normal-vs-Occasional Drinker
8.109600E-01
Normal-vs-Social Drinker
7.896600E-01
Non Drinker-vs-Daily Drinker
6.864200E-01
Non Drinker-vs-Weekly Drinker
9.632000E-01
Non Drinker-vs-Occasional Drinker
7.123600E-01
Non Drinker-vs-Social Drinker
1.433840E-01
Daily Drinker-vs-Weekly Drinker
7.651400E-01
Daily Drinker-vs-Occasional Drinker
9.978600E-01
Daily Drinker-vs-Social Drinker
3.082600E-01
Weekly Drinker-vs-Occasional Drinker
7.849000E-01
Weekly Drinker-vs-Social Drinker
2.119600E-01
Occasional Drinker-vs-Social Drinker
3.575400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.047800E-01
Normal-vs-Grade 2
4.039200E-01
Normal-vs-Grade 3
3.476000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.828400E-02
Grade 1-vs-Grade 3
4.310400E-02
Grade 1-vs-Grade 4
8.047800E-01
Grade 2-vs-Grade 3
5.241600E-01
Grade 2-vs-Grade 4
4.039200E-01
Grade 3-vs-Grade 4
3.476000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.343600E-01
Normal-vs-NonDiabetic
9.915600E-01
Diabetic-vs-NonDiabetic
3.380400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.480400E-01
Normal-vs-NoPancreatitis
8.081400E-01
Pancreatitis-vs-NoPancreatitis
3.221200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.751000E-01
Normal-vs-N1
8.823200E-01
N0-vs-N1
5.017200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.232200E-01
Normal-vs-TP53-NonMutant
6.673200E-01
TP53-Mutant-vs-TP53-NonMutant
3.5761000000023E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
